Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 13, 2026, 3:27 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1393–1416 of 1,823 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Media Clear all

Conditions: E-cigarette Use
Interventions: CATCH My Breath (CMB) program for E-cigarette prevention among adolescents, Texas Education Agency (TEA) required tobacco prevention program; Behavioral
Lead sponsor: The University of Texas Health Science Center, Houston; Other
Eligibility: 10 Years to 15 Years
Enrollment: 2,059 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2024
U.S. locations: 1
States / cities: Austin, Texas

Conditions: Otitis Media With Effusion, Food Hypersensitivity
Interventions: Food Allergy Testing, Adenoidectomy, BMT; Other · Procedure
Lead sponsor: University of Missouri-Columbia; Other
Eligibility: Up to 4 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2015
U.S. locations: 1
States / cities: Columbia, Missouri

Conditions: Atherosclerosis
Interventions: extended release niacin, ezetimibe; Drug
Lead sponsor: Walter Reed Army Medical Center; Federal
Eligibility: 30 Years and older
Enrollment: 400 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2009
U.S. locations: 2
States / cities: Washington D.C., District of Columbia • Takoma Park, Maryland

Conditions: Otitis Media
Interventions: 3-Part Intervention, 4-Part Intervention, 1-part intervention; Other
Lead sponsor: Children's Hospital of Philadelphia; Other
Eligibility: 2 Months to 18 Years
Enrollment: 55,779 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2010
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Myasthenia Gravis, Neuromuscular Disease, Neuromuscular Manifestations
Interventions: Social media recruitment, Self-Assessment, Follow-up; Behavioral
Lead sponsor: ZS Associates; Industry
Eligibility: 18 Years and older
Enrollment: 1,000 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025
U.S. locations: 1
States / cities: Evanston, Illinois

Conditions: Stress, Emotional
Interventions: ECA System; Behavioral
Lead sponsor: Boston Medical Center; Other
Eligibility: 18 Years to 50 Years · Female only
Enrollment: 61 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2016
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: End Stage Renal Disease, Anemia
Interventions: Roxadustat, Epoetin Alfa, Placebo; Drug · Other
Lead sponsor: Kyntra Bio; Industry
Eligibility: 18 Years to 75 Years
Enrollment: 161 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2012
U.S. locations: 25
States / cities: Tempe, Arizona • Pine Bluff, Arkansas • Azusa, California + 22 more

Conditions: Air Pollution
Interventions: Air filtration and building envelop modifications; Other
Lead sponsor: UConn Health; Other
Eligibility: 40 Years to 75 Years
Enrollment: 77 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018
U.S. locations: 1
States / cities: Farmington, Connecticut

Conditions: Type 1 Diabetes
Interventions: Social Media; Behavioral
Lead sponsor: Seattle Children's Hospital; Other
Eligibility: 13 Years to 18 Years
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2024
U.S. locations: 1
States / cities: Seattle, Washington

Conditions: Central Neuropathic Pain, Allodynia, Spinal Cord Injury
Interventions: Dextromethorphan, Lidocaine, Placebo (Dextromethorphan), Placebo (Lidocaine); Drug
Lead sponsor: Brigham and Women's Hospital; Other
Eligibility: 18 Years to 70 Years
Enrollment: 26 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2003 – 2008
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Major Depressive Disorder
Interventions: Low Dose Psilocybin, Placebo, Medium Dose Psilocybin; Drug
Lead sponsor: Yale University; Other
Eligibility: 18 Years to 65 Years
Enrollment: 18 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2026
U.S. locations: 1
States / cities: West Haven, Connecticut

Conditions: Smoking, Smoking Cessation, Smoking Reduction, Smoking Behaviors
Interventions: Reduction (relocation and reduction of personal smoking) and cessation, Resident Endorsement; Behavioral
Lead sponsor: Columbia University; Other
Eligibility: 18 Years and older
Enrollment: 405 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2025
U.S. locations: 1
States / cities: New York, New York

Conditions: Pain, Postoperative
Interventions: Naproxen sodium/Caffeine (BAY2880376), Naproxen sodium (Aleve), Caffeine, Placebo; Drug
Lead sponsor: Bayer; Industry
Eligibility: 16 Years and older
Enrollment: 193 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2020
U.S. locations: 1
States / cities: Salt Lake City, Utah

Conditions: Informed Consent
Interventions: Audio-visual telemedicine, Standard care; Procedure
Lead sponsor: University of Iowa; Other
Eligibility: 18 Years and older
Enrollment: 130 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015
U.S. locations: 1
States / cities: Iowa City, Iowa

Conditions: Schizophrenia, First Episode Psychosis
Interventions: search engine advertisement campaign; Behavioral
Lead sponsor: Northwell Health; Other
Eligibility: Not listed
Enrollment: 698 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2023
U.S. locations: 2
States / cities: Glen Oaks, New York • Queens, New York

Conditions: Schizophrenia
Interventions: 10 mg CVL-231 as IR formulation, 30 mg CVL-231 as slow-release MR formulation, 30 mg CVL-231 as medium release MR formulation, 30 mg CVL-231 as fast release MR formulation, 30 mg CVL-231 Target Release, Fasted, 30 mg CVL-231 Target Release, Fed; Drug
Lead sponsor: Cerevel Therapeutics, LLC; Industry
Eligibility: 18 Years to 55 Years
Enrollment: 16 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2022
U.S. locations: 1
States / cities: Tempe, Arizona

Conditions: Thyroid Eye Disease
Interventions: AMG 732, Placebo; Drug · Other
Lead sponsor: Amgen; Industry
Eligibility: 18 Years to 65 Years
Enrollment: 94 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2027
U.S. locations: 12
States / cities: Little Rock, Arkansas • Newport Beach, California • Jacksonville, Florida + 9 more

Conditions: Breast Cancer, Ovarian Cancer
Interventions: Adapted Family History Screening Program; Other
Lead sponsor: Emory University; Other
Eligibility: 25 Years and older · Female only
Enrollment: 3,209 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2028
U.S. locations: 1
States / cities: Atlanta, Georgia

Conditions: Attention Deficit Hyperactivity Disorder
Interventions: Sensory-Play Based (SenPlay) Intervention, Spontaneous, Free Play; Other
Lead sponsor: University of Oklahoma; Other
Eligibility: 36 Months to 71 Months
Enrollment: 12 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022
U.S. locations: 1
States / cities: Yukon, Oklahoma

Conditions: Otitis Media
Interventions: Tympanocentesis, Nose/throat swab, Observational; Procedure · Biological
Lead sponsor: Pfizer; Industry
Eligibility: 6 Months to 30 Months
Enrollment: 239 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2016
U.S. locations: 7
States / cities: Penfield, New York • Rochester, New York

Conditions: Brow Ptosis, Lid Ptosis
Interventions: Dysport; Drug
Lead sponsor: Kenneth Beer; Individual
Eligibility: 25 Years to 75 Years
Enrollment: 24 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2011 – 2012
U.S. locations: 1
States / cities: West Palm Beach, Florida

Conditions: Health Behavior, Health Care Utilization, Unprotected Sex, Sexually Transmitted Infections
Interventions: SafeSpace Sexual Health, SafeSpace General Health; Behavioral
Lead sponsor: Child Trends; Other
Eligibility: 14 Years to 18 Years · Female only
Enrollment: 1,000 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2026
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Sleep, Physical Activity, Family and Household, Computer, Attitude to, Adolescent Behavior
Interventions: Family Media Use Plan, Media Use Resources Awareness; Behavioral
Lead sponsor: University of Wisconsin, Madison; Other
Eligibility: 12 Years to 17 Years
Enrollment: 1,520 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2020
U.S. locations: 1
States / cities: Madison, Wisconsin

Conditions: Infertility, HIV Infections
Interventions: Sperm washing and testing for HIV contamination, Intrauterine Insemination; Other · Procedure
Lead sponsor: University of Missouri-Columbia; Other
Eligibility: 18 Years to 38 Years
U.S. locations: 1
States / cities: Columbia, Missouri

Search by objective public record fields.

Middle School Cluster Randomized Controlled Trial (RCT) to Evaluate E-Cigarette Prevention Program: CATCH My Breath

Food Allergy - Tubes - Adenoids (FATA) Trial

Comparative Study of the Effect of Ezetimibe Versus Extended-Release Niacin on Atherosclerosis

Improving Otitis Media Care With Clinical Decision Support

Validation and Scaling of Screening Program for Undiagnosed Myasthenia Gravis-Social Media Campaign Paired With a Self-moderated Assessment

Engaging Women With the Gabby System to Deliver Multiple Health-Related Behavioral Changes: A Feasibility Study

Study of Roxadustat (FG-4592) in Participants With End-Stage Renal Disease Receiving Maintenance Hemodialysis

Reducing Traffic Pollution Exposure Improves Blood Pressure

Social Media Use in Adolescent Diabetes Care

Clinical Neuropharmacology of Pain in Spinal Cord Injury- Dextromethorphan/Lidocaine Combination Clinical Trial

Psilocybin - Induced Neuroplasticity in the Treatment of Major Depressive Disorder

Supporting Smoke-Free Policy Compliance in Public Housing

Study to Find Out the Optimal Dose of Caffeine in the Combination Tablet of Naproxen Sodium and Caffeine in Patients Experiencing Moderate to Severe Pain After Having Wisdom Teeth Removed

Comprehension of Research Informed Consent When Applied Through a Telemedicine Medium

Using Digital Media Advertising to Reduce the Duration of Untreated Psychosis

Pharmacokinetics of CVL-231 Following Single Oral Administration of Modified- and Immediate-release Formulations in Fasted and Fed Healthy Participants

A Study of AMG 732 in Healthy Participants and Participants With Thyroid Eye Disease

Evaluating an Evidence-Based Family History Screening Program Adapted to Increase Reach and Uptake of Screening for BRCA-Associated Cancers in Rural Public Health Clinics

Sensory-Play Based (SenPlay) Intervention for Young Children With or At Risk for ADHD

Effect of Prevnar 13 on Ear Infections in Children

Brow Lifting With Dysport

Evaluation of the SafeSpace App Intervention

Youth Health and Social Media

HIV-discordant Couple Intrauterine Insemination